Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes (Q50973035)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 January 2015

Language	Label	Description	Also known as
English	Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes	scientific article published on 16 January 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

prostate cancer

1 reference

based on heuristic

inferred from title

20

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

13

object named as

D E Neal

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

Zsofia Kote-Jarai

1

object named as

Z Kote-Jarai

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

Elinor J. Sawyer

17

object named as

E J Sawyer

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

Antonis C Antoniou

19

object named as

A C Antoniou

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

author name string

C Mikropoulos

2

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

D A Leongamornlert

3

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

T Dadaev

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

M Tymrakiewicz

5

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

E J Saunders

6

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

M Jones

7

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

S Jugurnauth-Little

8

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

K Govindasami

9

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

M Guy

10

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

F C Hamdy

11

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

J L Donovan

12

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

J A Lane

14

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

D Dearnaley

15

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

R A Wilkinson

16

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

A Morgan

18

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

UK Genetic Prostate Cancer Study Collaborators, and ProtecT Study Group

21

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

language of work or name

0 references

publication date

16 January 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

26

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

4

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

756-761

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

The heritability of prostate cancer in the Nordic Twin Study of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Genetic variants associated with predisposition to prostate cancer and potential clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Germline mutations in HOXB13 and prostate-cancer risk

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Age specific and attributable risks of familial prostate carcinoma from the family-cancer database

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDV004

21 January 2018

Identifiers

10.1093/ANNONC/MDV004

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 March 2018

http://europepmc.org/abstract/MED/25595936

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50973035&oldid=2264142568"